Author

C. Ngo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:deep learning· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Approach:biophysical modeling· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

A. Ballesta· 1 shared A. Banito· 1 shared A. Broggi· 1 shared A. Jarosch· 1 shared A. Orynbek· 1 shared A. Ritter· 1 shared A. Sansoni· 1 shared A. ZARUBICA· 1 shared

Activity by Year

2024-2024 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ballesta

Author profile →

4 papers

Recent·Most cited

Super-enhancer-driven CACNA2D2 is an EWSR1::WT1 signature gene encoding a diagnostic marker for desmoplastic small round cell tumor (DSRCT)

F. H. Geyer, A. Ritter, S. Kinn-Gurzo, T. Faehling, J. Li, A. Jarosch, C. Ngo, E. Vinca, K. Aljakouch, A. Orynbek, S. Ohmura, T. Kirchner, R. Imle, L. Romero-Perez, S. Bertram, , F. Cidre-Aranaz

The paper identifies CACNA2D2 as a super-enhancer-driven target of EWSR1::WT1 and demonstrates its utility as a diagnostic biomarker for DSRCT.

bioRxiv · Jul 17, 2024 · PreprintCancer Biology

Integrated multiomic profiling reveals SWI/SNF subunit-specific pathway alterations and targetable vulnerabilities

J. Bretones-Santamarina, C. Astier, M. Garrido, L. Colmet-Daage, T. I. Roumeliotis, E. Anthony, M. Pardo, M. Chasseriaud, P. Gestraud, C. Ngo, D. Morel, R. Chabanon, J. S. Chaudhary, E. Del Nery, S. Postel-Vinay, A. Ballesta

The paper identifies pathway alterations and targetable vulnerabilities in SWI/SNF-defective cancers through multiomic profiling and drug screening.

bioRxiv · Jul 16, 2024 · PreprintCancer Biology

Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections

C. Ngo, C. Pierini-Malosse, K. Rahmani, M. Valente, N. Collinet, G. Bessou, C. Guerry, M. Fabregue, S. Mathieu, S. Sharkaoui, S. Mazzoli, A. Sansoni, F. Fiore, C. Laprie, L. Alexopoulou, , E. Tomasello

This study shows that plasmacytoid dendritic cells (pDCs) and their interferons are dispensable or harmful in systemic and respiratory viral infections in mice.

bioRxiv · May 20, 2024Immunology

STECode: an automated virulence barcode generator to aid clinical and public health risk assessment of Shiga toxin-producing Escherichia coli

E. M. Sim, W. Fong, C. Suster, J. E. Agius, S. Chandra, B. Suliman, Q. Wang, C. Ngo, C. Finemore, S. C.-A. Chen, K. Basile, V. Sintchenko

STECode automates virulence barcode generation for Shiga toxin-producing E. coli to assess pathogenic potential from sequencing data.

bioRxiv · May 7, 2024 · PreprintMicrobiology